ClinicalTrials.gov
public full text
Public Domain
Phase Ⅳ Clinical Trial of Recombinant Hepatitis E Vaccine（Hecolin®）
The purpose of this study is to determine the safety and immunogenicity of the recombinant hepatitis E vaccine in people older than 65 years, and evaluate the efficacy of hepatitis E vaccine in this population.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Clinical Trial of Recombinant Hepatitis E Vaccine#311197
- A Clinical Trial to Evaluate a Recombinant Hepatitis E Vaccine in Healthy Adults#1094235
- Hepatitis E virus seroprevalence in South Africa from a multi-site study among HIV-negative and HIV-positive adults and age-stratified children (2-17 Years)#243519
- Behavior of Family in Practice Hepatitis B Immunization at Baby 0-7 Days Old#1005024
- Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Co-administered With an Hepatitis A Virus Vaccine#907581
Record · ID 886404
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive